EP Patent

EP3844500A4 — RP182 COMPOSITIONS AND METHODS

Assigned to NantBio Inc · Expires 2022-05-11 · 4y expired

What this patent protects

Patent listed against Gattex Kit.

Drugs covered by this patent

Gattex Kit (TEDUGLUTIDE) · Takeda

Patent Metadata

Patent number: EP3844500A4
Jurisdiction: EP
Classification: —
Expires: 2022-05-11
Drug substance claim: No
Drug product claim: No
Assignee: NantBio Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.